“The right kind of innovation doesn't just build companies, it builds countries. Investing in pre-seed and seed-stage African startups by mapping 300+ proven business models to Africa's infrastructure gaps.”
Ajim Capital is an Austin-based, Africa-focused pre-seed and seed-stage venture capital firm founded in 2022 by Eunice Ajim, a Cameroonian-American two-time tech founder who previously built and scaled a startup to $10 million+ in valuation before exit. Named a Forbes 30 Under 30 in Venture Capital (2026), Ajim operates a solo GP model with a proprietary research framework: she has catalogued 300+ proven business models from India, China, and Latin America, mapping each to Africa's specific infrastructure gaps, mobile-first consumer behaviours, and regulatory environments. This pattern-recognition approach replaces the guesswork that characterises many early-stage Africa investments.
Fund I deployed $10 million across 30+ companies, and Fund II ($20 million target) is currently deploying with larger cheques of $250K to $500K at pre-seed and seed stage. The portfolio spans six sectors: fintech (payments, lending, banking infrastructure), commerce (B2B trade, procurement, marketplaces), logistics (last-mile delivery, supply chain, fleet tech), vertical SaaS (healthcare, agritech, proptech), AI and automation (enterprise AI, LLM infrastructure), and developer tools (APIs, DevOps, cloud). Notable portfolio companies include Raenest ($14.3 million raised in follow-on), Dojah (identity verification and fraud prevention), Eazipay (payroll and HR), BuuPass (transportation ticketing), Flex Finance (spend management), Chpter (social commerce), Tyms (accounting software), and Mira (point-of-sale systems). Ajim's operating philosophy is "Equip, Educate, Empower": she works alongside founders as an operator rather than just a board member, providing strategic guidance, hiring support, distribution strategy, and fundraising assistance.
| Name | Role | X/Twitter | |
|---|---|---|---|
| Eunice Ajim | Founder & Managing Partner | Not disclosed |